ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree.
Ceren TuncaFulya AkçimenCemre CoşkunAslı Gündoğdu-EkenCemile KocogluBetül ÇevikCan Ebru Bekircan-KurtErsin TanA Nazlı BaşakPublished in: European journal of human genetics : EJHG (2018)
Amyotrophic lateral sclerosis (ALS) is a late-onset motor neuron disease with mostly dominant inheritance and a life expectancy of 2-5 years; however, a quite common occurrence of atypical forms of the disease, due to recessive inheritance, has become evident with the use of NGS technologies. In this paper, we describe a family with close consanguinity for at least four generations, suffering from a slowly progressive form of ALS. Spastic walking is observed since teenage years, while bulbar symptoms start much later, at the fifth or sixth decade of life. Patients usually die because of respiratory failure. Using whole-exome sequencing, we identified a novel homozygous p.(Val94Ala) (c.281T>C) (NG_052910.1) (NM_006459) variation in the endoplasmic reticulum lipid raft associated protein 1 (ERLIN1) gene, which segregates with the disease in the family. Here we suggest that ERLIN1 variants, previously shown in juvenile hereditary spastic paraplegia cases, may also be the cause of a slowly progressive early-onset ALS, starting with upper motor neuron features and developing into classical ALS with the addition of lower motor neuron dysfunction. We also demonstrate that ATP-binding cassette subfamily C member 2 (ABCC2) gene, responsible for hyperbilirubinemia, is linked to ERLIN1.
Keyphrases
- amyotrophic lateral sclerosis
- early onset
- late onset
- multiple sclerosis
- copy number
- mitochondrial dna
- endoplasmic reticulum
- respiratory failure
- end stage renal disease
- genome wide
- chronic kidney disease
- ejection fraction
- risk assessment
- cerebral palsy
- prognostic factors
- photodynamic therapy
- botulinum toxin
- peritoneal dialysis
- intensive care unit
- gene expression
- intellectual disability
- dna methylation
- acute respiratory distress syndrome
- transcription factor
- duchenne muscular dystrophy
- lower limb
- patient reported outcomes